Showing results (131-140 of 3,521) with videos related to
Sort By:
Pageof 353
The Journal of Biological Chemistry|November 4, 1992
Transgenic mice expressing full-length human apolipoprotein B-100. Full-length human apolipoprotein B mRNA is essentially not edited in mouse intestine or liverW Xiong, E Zsigmond, A M Gotto, et al.Peptides|May 1, 1983
The application of an improved solid phase synthetic technique to the delineation of an antigenic site of apolipoprotein A-IIP K Bhatnagar, S J Mao, A M Gotto, et al.Journal of Lipid Research|August 1, 1980
The measurement of apolipoprotein A-I in human plasma by electroimmunoassayJ P Miller, S J Mao, J R Patsch, et al.Biochimica Et Biophysica Acta|February 26, 1979
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical propertiesC J Packard, J Shepherd, S Joerns, et al.The Journal of Biological Chemistry|February 15, 1993
High density lipoprotein interconversions in rat and man as assessed with a novel nontransferable apolipopeptideG Ponsin, T Pulcini, J T Sparrow, et al.Biochimica Et Biophysica Acta|November 6, 1989
Metabolism of apolipoprotein A-IV in ratG Ghiselli, W L Crump, R Musanti, et al.The Journal of Biological Chemistry|December 25, 1979
Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitroS Eisenberg, J R Patsch, J T Sparrow, et al.Biochemistry|October 23, 1984
In vitro binding of synthetic acylated lipid-associating peptides to high-density lipoproteins: effect of hydrophobicityG Ponsin, K Strong, A M Gotto, et al.The Journal of Clinical Investigation|December 1, 1984
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjectsC J Packard, A Munro, A R Lorimer, et al.Circulation Research|May 23, 2001
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapyS Lutucuta, C M Ballantyne, H Elghannam, et al.Pageof 353